RTF1 activators encompass a range of chemical entities that can either directly or indirectly upregulate or enhance the functional activity of the RTF1 protein, a crucial component involved in transcriptional processes. A notable member of this class is 5-Azacytidine, a DNA methyltransferase inhibitor. By curtailing DNA methylation, 5-Azacytidine fosters the transcriptional activation of specific genes. Similarly, Trichostatin A, an inhibitor of histone deacetylases (HDACs), paves the way for a more open chromatin structure. Such an open configuration can favor the machinery of transcriptional elongation complexes, providing a conducive environment for RTF1's functionality.
Moreover, certain compounds target specific intermediates that indirectly influence RTF1's role. For instance, DRB, a CDK9 inhibitor, impacts the function of the positive transcription elongation factor b (P-TEFb), thereby indirectly shaping transcriptional elongation processes that involve RTF1. Another compound, JQ1, curbs the bromodomain-containing proteins BRD4, which hold significant roles in transcriptional elongation. On the other hand, chemicals like Vorinostat and RG2833 are HDAC inhibitors that mold the chromatin structure in a manner favorable for transcription, thereby possibly amplifying RTF1's functional spectrum. Lastly, compounds such as C646 and M344, which inhibit p300/CBP and HDACs respectively, further reinforce the intricate network of RTF1 activators.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
This compound inhibits the bromodomain-containing proteins BRD4, which has roles in transcriptional elongation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that can influence chromatin structure, potentially affecting transcriptional machinery. | ||||||
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Known to influence NF-kB signaling, it can indirectly impact transcription processes. | ||||||
RGFP 109 | 1215493-56-3 | sc-477157 | 10 mg | $300.00 | ||
Another HDAC inhibitor that could promote a transcription-favorable chromatin state. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
A p300/CBP inhibitor, impacting histone acetylation, and potentially transcriptional elongation. | ||||||
M 344 | 251456-60-7 | sc-203124 sc-203124A | 1 mg 5 mg | $109.00 $322.00 | 8 | |
Inhibits HDACs, promoting open chromatin structure conducive to transcription. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibits the NEDD8-activating enzyme, affecting proteasome-mediated degradation, which can indirectly impact transcriptional machinery. | ||||||
Epz004777 | 1338466-77-5 | sc-507560 | 100 mg | $575.00 | ||
A DOT1L inhibitor, affecting histone methylation and potentially transcription elongation. | ||||||
9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-β-D-ribofuranosyl]-9H-purin-6-amine | 1380288-87-8 | sc-500607 | 50 mg | $13500.00 | ||
Another DOT1L inhibitor, modulating histone methylation states which can indirectly affect transcription. | ||||||